Skip to main content
If you live with both excess weight and elevated urate, the advice you hear can feel contradictory: lose weight to help control urate, yet beware that rapid weight loss can stir up gout. A new trial published on November 1 in Diabetes Care gives both messages a shared frame. It tested three calorie-restricted diets head to head in men with hyperuricemia, the medical term for elevated urate, and found they worked about equally well for weight loss — while the opening week deserved special care, as urate became temporarily unstable and gout attacks peaked early.
That combination — a tie on the main result, plus a warning tucked inside the first days — is what makes this trial worth a careful read. It is not a story about a miracle diet. It is a story about the calorie deficit doing the heavy lifting, and about why the speed of the start matters as much as the plan itself.
The result in brief
- Three calorie-restricted diets, one similar outcome: a low-carb diet, the DASH eating pattern, and a balanced low-purine diet each produced comparable weight loss and urate reduction over 12 weeks.
- The average loss was substantial: among the 85 participants who completed follow-up, average weight loss was 8.47 kilograms, or 9.3 per cent of starting weight.
- No winner could be declared: there was no statistically significant difference between the groups in weight loss or urate reduction after 12 weeks.
- Practicality separated the plans: participants stuck better to the DASH plan, and that group lost less lean tissue than the low-carb group.
- The first week was the risk window: home measurements recorded a transient instability of urate early on, coinciding with an early peak in gout attacks.
- The practical message is steadiness, not severity: choose a plan that reduces energy intake, preserves meal quality, and can be maintained, rather than the most restrictive regimen available.
Three plates, one calorie rule
The trial enrolled 102 overweight or obese men with hyperuricemia. Each man was assigned to one of three eating plans for 12 weeks, and every plan was calorie-restricted. That shared restriction is the key design detail: the study was comparing three structured ways to reduce energy intake, to learn whether the composition of the diet changed the outcome once calories were held down.
| Diet in the trial | What it emphasised | What it limited |
|---|---|---|
| Low-carb diet | Fewer carbohydrates, with energy coming more from protein and fat | Carbohydrate-rich foods |
| DASH eating pattern | Vegetables, fruits, whole grains, legumes, nuts, and low-fat dairy products | Saturated fat, sugary foods, and excess salt |
| Balanced low-purine diet | A balanced pattern with lower purine intake | Purine-rich foods that raise urate load |
A reader meeting these three plans for the first time might expect a clear ranking. Low-carb eating has a strong following, and a low-purine plan sounds tailor-made for elevated urate, since purines break down into uric acid. DASH, designed for blood pressure rather than gout, might look like the outsider. The trial put those expectations to a direct test, and they did not survive it.
It is worth pausing on what a calorie-restricted plan actually asks of a person. It is not simply a list of allowed and forbidden foods. It is a daily energy budget, and every meal is a spending decision inside that budget. Two plans can look completely different on the plate and still deliver a similar deficit, and a similar deficit often means similar weight change.
A tie, not a winner
After 12 weeks, there was no statistically significant difference between the groups in weight loss or in urate reduction. In plain language, the three diets finished so close together that the gap between them could plausibly be chance rather than a real advantage for any one plan.
That kind of result can disappoint readers who want a verdict, but a tie is liberating information. If three quite different patterns produce a similar result when calories are restricted, then the choice of pattern can be guided by other things: which foods a person enjoys, which plan fits their cooking habits, and which one their clinician considers suitable alongside their other health conditions.
The average result also deserves a second look. An average loss of 8.47 kilograms across the 85 participants who completed follow-up is a large change in 12 weeks, and 9.3 per cent of starting weight is the kind of reduction that clinicians take seriously for metabolic health. Read honestly, though, it is an average across people who stayed in the trial, not a promise to any individual, and it was achieved inside a structured trial rather than by people improvising alone at home.
There is a related point about urate itself. Weight loss and urate reduction moved together in broad terms, but the trial does not present diet as a replacement for medical care. The report is explicit that its results should not be read as a reason to stop urate-lowering therapy. A diet can be an important part of treatment, but in this trial it sits alongside prescribed medication and monitoring of urate levels, not instead of them.
Why adherence beat the diet label
If the three diets tied on weight and urate, what separated them? The answer, according to the trial report, was practicality. Participants adhered better to the DASH plan than to the other plans, and the DASH group also lost less lean tissue than the low-carb group. Those two observations belong together, because they describe the same underlying idea from two angles: a plan only works if a person can stay on it, and a plan that preserves muscle while fat comes off is a better result than the same scale weight achieved by losing more lean tissue.
DASH is built from ordinary foods. Its pattern centres on vegetables, fruits, whole grains, legumes, nuts, and low-fat dairy products, while limiting saturated fat, sugary foods, and excess salt. There is nothing exotic in that list, and that ordinariness may be exactly why people stayed with it. A plan made of familiar foods, in portions that still feel like meals, asks less willpower per day than a plan that redraws the whole plate.
The lean tissue finding adds a second reason to take adherence seriously. Losing weight is not the same as losing fat: when a diet strips away lean tissue along with fat, the person can end up lighter but weaker. The DASH group lost less lean tissue than the low-carb group, which suggests the quality of the loss differed, and quality determines whether a result is worth keeping.
None of this proves that DASH is the best pattern for every person with elevated urate. The trial report itself is careful on that point: the findings do not show that the pattern is best for everyone, only that sustainability is worth considering as seriously as a diet’s name suggests. The broader context supports that reading. The original report of the trial notes that the NIH position is that gradually losing excess weight can help control urate levels, alongside limiting alcohol, sugary drinks, offal, large amounts of red meat, and certain seafood. It also notes that NICE warns there is not enough evidence that any particular diet alone prevents attacks or reliably lowers urate levels in everyone, and therefore recommends a healthy, balanced diet rather than a universal gout menu.
The first week: where the good news gets complicated
The most important passage in the trial report is not the tie. It is the warning about the first week. Home capillary measurements recorded a transient instability of urate as weight loss began, and that instability coincided with the early peak of gout attacks: the moment weight began to come down was also the moment urate behaved most unpredictably.
That pattern has a logic to it, even if it feels unfair. Rapid weight loss breaks down tissue, and tissue breakdown releases purines, which in turn raise urate. The body, in the early days of a deficit, is adjusting to a new energy regime, and urate levels can swing before they settle. The trial does not suggest that this early turbulence cancels the later benefit. It suggests that the beginning of a weight-loss plan is a period to handle with care rather than enthusiasm, especially for someone who already has gout.
The practical point is direct: the first week is the worst time for unsupervised changes, such as stopping or starting medication or pushing a deficit harder, and anyone with gout, frequent attacks, kidney disease, or urate-lowering therapy should discuss a plan with a doctor or qualified dietitian before beginning. Rapid weight loss is not a harmless experiment for a person who already has gout, and the trial’s average result is not a personal target to reproduce alone in 12 weeks.
Questions readers are asking
What is hyperuricemia, and how is it different from gout?
Hyperuricemia means elevated levels of urate in the blood. Gout is the condition that can result when excess urate forms crystals in joints and causes painful inflammation. Not everyone with hyperuricemia develops gout, but elevated urate is the underlying condition that gout grows from.
Did one diet win for weight loss?
No. The low-carb diet, the DASH pattern, and the balanced low-purine diet all produced similar weight loss and similar urate reduction after 12 weeks, with no statistically significant difference between the groups. The trial’s useful lesson is that the calorie restriction shared by all three plans mattered more than the label on any one of them.
Why did the DASH group do better on adherence and lean tissue?
The report does not reduce this to a single cause, but the pattern fits what diet research often finds: a plan built from familiar, varied foods is easier to sustain than a more restrictive one, and a sustainable plan protects muscle better. The DASH group adhered better and lost less lean tissue than the low-carb group, which points to sustainability as a real outcome, not just a matter of convenience.
Is it safe to start a calorie-restricted diet if I have gout?
This trial is not a personal safety clearance, and its own warning cuts against treating it as one. The first week brought transient urate instability and an early peak in gout attacks, so a person with gout, frequent attacks, kidney disease, or urate-lowering therapy should discuss any weight-loss plan with a doctor or a qualified dietitian first. Diet can be an important part of treatment, but it is not a substitute for prescribed medication and monitoring.
Does this trial mean diet alone can control urate?
No. The guidance context around the trial points the other way. The NIH notes that gradual weight loss can help control urate, while NICE cautions that no particular diet alone has been shown to prevent attacks or reliably lower urate in everyone, and recommends a healthy, balanced diet instead of a single prescribed menu. The trial supports diet as a valuable part of care, within medical supervision, not as a standalone cure.
Who this trial does — and does not — speak for
Every trial has a boundary, and this one is unusually clear. All 102 participants were men. The findings speak most directly to overweight or obese men with hyperuricemia, and they do not automatically extend to women, whose urate metabolism and gout risk differ, or to people of normal weight, or to children and adolescents.
Size is a second boundary. One hundred and two people is a modest trial, and 85 completed follow-up. That is enough to compare three groups on their primary outcome, but not enough to settle smaller questions, such as whether one diet helps a particular subgroup more, or how results hold up beyond 12 weeks.
A third boundary is supervision. Trial participants received structured plans and were followed closely, with home capillary measurements capturing urate changes that a person at home would never see. That monitoring is part of why the first-week warning could be detected at all. Outside a trial, without that monitoring, the same early instability could pass unnoticed until it arrived as a gout attack. Those limits do not weaken the trial’s core contribution. They define it: when calories are restricted, the diet pattern did not change the result for these men over 12 weeks, except in the practical matters of adherence and lean tissue, which may matter more in real life than the scale alone suggests.
What this means if you are counting calories
For readers who track their own intake, the trial reframes the usual question. Instead of asking which diet is best in the abstract, it invites a more personal question: which calorie-restricted pattern can you follow for 12 weeks without hating it, and which one leaves you with enough energy and muscle to keep moving? The trial’s tie means the honest answer may differ from person to person, and a clinician or dietitian is the right person to help settle it.
That reframing connects directly to the arithmetic of a calorie deficit: the gap between what the body burns in a day and what a person eats. Estimating the first half of that gap is where many plans go wrong. Total daily energy expenditure is the standard estimate for daily burn, and understanding what TDEE actually measures turns a vague target into a number that can be planned around. The same lesson about structured, supervised restriction appears in other recent research covered on this site, including a trial in which a supervised low-calorie programme helped younger adults with early type 2 diabetes reach remission, described in this earlier article on the diabetes remission trial, and a two-year analysis showing that moderate restriction improved diet quality when it was supported by education, covered in this earlier article on calorie restriction and diet quality. In each case, the structure and the support mattered as much as the size of the cut.
If you live with elevated urate and are thinking about a calorie-restricted plan, take the trial’s two messages together rather than separately. The first message is encouraging: the pattern may matter less than the deficit, so you have room to choose a plan you can live with. The second message is cautionary: the first week needs care, medication is not something to adjust on your own, and a doctor or dietitian should be part of the plan from the start.
For a practical starting point, the TDEE calculator estimates daily energy needs from age, height, weight, and activity level, giving you the maintenance figure from which any deficit should be planned and discussed with a clinician. Use it as a planning tool, not as a prescription: choose the pattern you can sustain, start steadily, and treat the first week with the care it deserves.
